Skip to content

Recovering From Bariatric Surgery: the Effects of Early Initiated and Supervised Mobilization

Recovering From Bariatric Surgery: the Effects of Early Initiated and Supervised Mobilization

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06222151
Enrollment
112
Registered
2024-01-24
Start date
2024-04-22
Completion date
2027-12-26
Last updated
2026-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery, Mobilization, Physical Activity, Postoperative Pain, Acute, Postoperative Pain, Chronic

Keywords

Pain Coping, Bariatric Surgery, Postoperative Pain, Physical Activity, Mobilization

Brief summary

The aim is to investigate the effect of early initiated and supervised mobilization continued after discharge as management of postoperative pain and recovery following obesity surgery, including patient experiences, pain coping, physical functionality and quality of life.

Detailed description

Study aims; 1. To investigate the effect of mobilization as pain management following obesity surgery. 2. To investigate patient experiences with mobilization and postoperative pain, including the influence of mobilization on patients' ability to cope with pain and an identification of facilitating factors and barriers towards early mobilization. 3. To assess the effect of mobilization on postoperative recovery, including the general physical activity level, physical function, and quality of life among patients discharged after obesity surgery. The PhD study consists of two sub-studies. Study 1: Effect of early mobilization as pain management in patients recovering from obesity surgery. The study is a single center randomized controlled trial (RCT). Participants will be randomized with an allocation ratio of 1:1. Study 2: Patient experiences with early mobilization and postoperative pain after surgery - An interview study Patients participating in both interventions (group A), will be invited to participate in two individual semi structured interviews.

Interventions

OTHERIntervention 1: Mobilization during hospitalization

Surgical ICU Optimal Mobilization Score (SOMS) will be used to initiate early mobilization. SOMS consists of five levels of mobilization reaching from no activity to ambulation. Thirty minutes after PACU-arrival, the patient will be asked to do lower leg exercises. If this is possible, the patient will advance to the next level of mobilization. If not possible, level zero is recorded and the patient rests for another 30 minutes before attempting level one again. This continues until the patient succeeds with level four. Safety criteria for advancing to the next level of mobilization are based on criteria for mobilizing patients in the ICU. The intervention group will receive standard care with additional supervised mobilization while hospitalized. This mobilization consist of walking 1000 steps on postoperative day (POD) 0 and 500 steps on POD1 before discharge. Step counts are measured using pedometers.

OTHERIntervention 2: Mobilization the first 4 postoperative weeks

Intervention 2 will start the first weekday after discharge and continue for 4 weeks. Four supervised physical activity sessions and 8 sessions using telerehabilitation. The activities are low-intensity exercises (walking and lightly strength training using resistance bands) with progressed intensity throughout the weeks. The exercises will be individually progressed to meet the participant's level of activity, as it is important the participants benefit as much as possible from the intervention. The participants will receive information about different possibilities for leisure activities, for motivation to continue physical activity after the first 4 weeks.

OTHERControl group

The control group receives standard care. Patients are mobilized to sit at the bedside before being transferred to the surgical ward. However, it is not used as prophylactic pain management nor is there a structured evidence based protocol with regard to mobilization. The control group will also be equipped with pedometers. They are encouraged to mobilize, and they receive a form in which they can write down mobilization for each hour. There is no planned supervised mobilization. As patients in the control group are assigned to standard care, they will not receive any supervised physical activity after discharge.

Sponsors

Esbjerg Hospital - University Hospital of Southern Denmark
Lead SponsorOTHER
Novo Nordisk A/S
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The patients will be randomized into the intervention or control group. To assess the effect of the two interventions separately and independent of each other and to avoid inequality at the starting point of intervention 1 and 2, the patients will at the starting point be randomized into four different groups: A) Intervention 1/Intervention 2, B) Intervention 1/Control 2, C) Control 1/ Intervention 2 D) Control 1/Control 2 (Figure 1). This procedure will enable evaluation of one intervention group versus one control group who are different at each time point.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* The ability to read and understand the Danish language

Exclusion criteria

* Preoperative dependence of walking aids * Vision impairment * Previous syncopes or epilepsy * Admission to the intensive care unit after surgery * Acute complications during hospital admission * Patients are excluded at baseline if they have an oxygen saturation below 90% or a systolic blood pressure above 180 mmHg

Design outcomes

Primary

MeasureTime frameDescription
Abdominal pain24 hours post surgeryAbdominal pain measured using a visual analog scale (VAS) of 0-10. A higher score indicates a worse pain.
Physical functionBaseline, 1 month postoperative and 6 months postoperativeA 6 minute walk test measured in metres

Secondary

MeasureTime frameDescription
Abdominal painAt baseline, during intervention 1, 1 month postoperative and 6 months postoperativeAbdominal pain measured using a visual analog scale (VAS) of 0-10. A higher score indicates a worse pain.
Morphine equivalent consumptionAt baseline, during intervention 1, at discharge (at the end of intervention 1), 1 month postoperative and 6 months postoperativeMeasured in milligram intravenous
Patient reported pain experiencesAt baseline, during intervention 1, 1 month postoperative and 6 months postoperativeAPS-POQ-R-D questionnaire.
Pain self-efficacyAt baseline, during intervention 1, 1 month postoperative and 6 months postoperativePSEQ-DK questionnaire. Pain self-efficacy is measured on a score of 0-60. A higher score indicates a greater pain self-efficacy.
Pain catastrophizingAt baseline, during intervention 1, 1 month postoperative and 6 months postoperativePain Catastrophizing Scale questionnaire. Pain Catastrophizing is measured on a score of 0-52. A higher score indicates a higher pain catastrophizing.
Postoperative nausea and vomitingDuring intervention 1, at discharge (at the end of intervention 1), 1 month postoperative and 6 months postoperativeOn a visual analog scale (VAS) of 0-10. A higher score indicates worse nausea.
Health related quality of life (SF-36)At baseline, during intervention 1, 1 month postoperative and 6 months postoperativeQuestionnaire SF-36. Health related quality of life is measured at a scale of 0-100. A higher score indicates a greater quality of life.
Physical activityAt baseline, 1 month postoperative and 6 months postoperativeMeasured using accelerometers - minutes low/medium/high activity performed per hour. Measured for 7 days at baseline, 7 days 1 month postoperative and 7 days 7 months postoperative
Readmission1 month postoperative and 6 months postoperativeReadmissions during study period

Countries

Denmark

Contacts

CONTACTNanna Marie Christiansen
nanna.marie.christiansen2@rsyd.dk+45 20670937
CONTACTBibi Gram
bgram@health.sdu.dk+45 79182356

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 21, 2026